• 1119 Citations
  • 15 h-Index
1981 …2017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Wahid T. Hanna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
von Willebrand Diseases Medicine & Life Sciences
Hemophilia A Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences
Factor VIII Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Antithrombin III Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
temozolomide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2017

  • 1119 Citations
  • 15 h-Index
  • 25 Article
  • 3 Letter
117 Citations (Scopus)

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

ACT IV trial investigators, Oct 1 2017, In : The Lancet Oncology. 18, 10, p. 1373-1385 13 p.

Research output: Contribution to journalArticle

Brain Edema
Control Groups
9 Citations (Scopus)

Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma

Craig, M., Hanna, W., Cabanillas, F., Chen, C. S., Esseltine, D. L., Neuwirth, R. & O'Connor, O. A., Jan 1 2014, In : British Journal of Haematology. 166, 6, p. 920-928 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
21 Citations (Scopus)

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease

Metjian, A. D., Wang, C., Sood, S. L., Cuker, A., Peterson, S. M., Soucie, J. M., Konkle, B. A., Boyd, M., Roy, G., Forman, E., Marandola, J., Homans, A. C., Granat, M., Lusher, J., Fleming, P., DiMichele, D., Goldberg, I., Saidi, P., Schwartz, R., Desposito, F. & 142 others, Joseph, D., Kouides, P. A., La Franco, J., Coyle, T., Dhar, N., Porter, J., Frank, M., Lipton, R., Bosch, M., Holmberg, R. P., Menza, L., Cohen, A., White, E., Guerrera, M., Guelcher, C., Kessler, C., Jacobs, H., Massey, G., Nolte, M., Werner, E., Stewart, K., Ragni, M., Jaworski, K., Rogers, J. S., Webber, S., Jubelirer, S., Arden, D., Casella, J., Underland, T., Panckeri, K., Palumbo, L., Sabio, H., Smith, A., Sharma, V., Ashby, P., Radulescu, V., Hanna, W., Zimmerman, C., Neff, A., Hudson, M. G., Reiss, U., Grant, R., Key, N., Nielsen, B., Dunn, A., Gutting, K., Watts, R., Noa, M. C., Abshire, T., Bryant, C., Ameri, A., Crenshaw, V., Kuriakose, P., Lambing, A., Heggie, G., Kovats-Bell, S., Inoue, S., Ruff, J. A., Mitchell, D., Sandon-Kleiboer, E., Kraut, E., Witkoff, L., Gruppo, R., Chambers, A., Kerlin, B., Lupia, C., French, J., Hibner, S., Shapiro, A., May, S., Alexander, S., Hopewell, S., Bockenstedt, P., Pipe, S., Mathis, D., Zakarija, A., Harris, S., Thompson, A., Allen, G. A., Brummel, A. T., Tarantino, M., Riedel, A., Reding, M., Curoe, S., Pruthi, R., Schmidt, K., Kralovetz, K., Charles, J., Diamond, C., Drozdowicz, P., Gill, J. C., Haar, J., Hoots, W. K., Gonzalez, V., Leissinger, C., Schmidt, C. V., Stine, K., Eckert, G., Sexauer, C., Kiplinger, F., Amerson, P., Johnson, E., Buchanan, G., Torres, R., DiPaola, J., Lammer, M., Wicklund, B., Nelson, D., Haire, W. D., Hanlon, E., Manco-Johnson, M., Geraghty, S., Yaish, H., Green, J., Young, G., McGinty, K., Herbst, K., Glass, C., Glader, B., Zoland, J. M., Medeiros, D., Omatsu, D. A., Ducore, J., Herr, M., Koerper, M., Karp, S., Lovejoy, A. E., Farrow, K., Ewing, N., Pullens, L., Meadows, L., Tackney, A., Mignacca, R., Patterson, F., Bernstein, J., Berkowitz, B., Thompson, A. R., Brower, C., Recht, M., Granger, K., Schulz, L. & Stewart, A., Jul 10 2009, In : Haemophilia. 15, 4, p. 918-925 8 p.

Research output: Contribution to journalArticle

von Willebrand Diseases
von Willebrand Factor
Type 3 Von Willebrand's Disease
104 Citations (Scopus)

Time course of early response to chemotherapy in non-small cell lung cancer patients with18F-FDG PET/CT

Nahmias, C., Hanna, W., Wahl, L. M., Long, M. J., Hubner, K. & Townsend, D. W., May 1 2007, In : Journal of Nuclear Medicine. 48, 5, p. 744-751 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Fluorodeoxyglucose F18
Drug Therapy
142 Citations (Scopus)

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: Analysis from the Hemophilia and Thrombosis Research Society Registry

Parameswaran, R., Shapiro, A. D., Gill, J. C., Kessler, C. M., Abshire, T., Angiolillo, A., Boggio, L., Cohen, A., DiMichele, D., Hanna, W., Hoots, K., Hord, J., Key, N., Konkle, B., Kouides, P., Kurczynski, E., Marks, P., Palascak, J., Pipe, S., Ragni, M. & 6 others, Rivard, G., Shopnick, R., Tarantino, M., Valentino, L., Watts, R. & White, G., Mar 1 2005, In : Haemophilia. 11, 2, p. 100-106 7 p.

Research output: Contribution to journalArticle

Hemophilia A